Literature DB >> 15183197

Impact of pulmonary arterial endothelial cells on duroquinone redox status.

Marilyn P Merker1, Robert D Bongard, Gary S Krenz, Hongtao Zhao, Viola S Fernandes, Balaraman Kalyanaraman, Neil Hogg, Said H Audi.   

Abstract

The study objective was to use pulmonary arterial endothelial cells to examine kinetics and mechanisms contributing to the disposition of the quinone 2,3,5,6-tetramethyl-1,4-benzoquinone (duroquinone, DQ) observed during passage through the pulmonary circulation. The approach was to add DQ, durohydroquinone (DQH2), or DQ with the cell membrane-impermeant oxidizing agent, ferricyanide (Fe(CN)6(3)-), to the cell medium, and to measure the medium concentrations of substrates and products over time. Studies were carried out under control conditions and with dicumarol, to inhibit NAD(P)H:quinone oxidoreductase 1 (NQO1), or cyanide, to inhibit mitochondrial electron transport. In control cells, DQH2 appears in the extracellular medium of cells incubated with DQ, and DQ appears when the cells are incubated with DQH2. Dicumarol blocked the appearance of DQH2 when DQ was added to the cell medium, and cyanide blocked the appearance of DQ when DQH2 was added to the cell medium, suggesting that the two electron reductase NQO1 dominates DQ reduction and mitochondrial electron transport complex III is the predominant route of DQH2 oxidation. In the presence of cyanide, the addition of DQ also resulted in an increased rate of appearance of DQH2 and stimulation of cyanide-insensitive oxygen consumption. As DQH2 does not autoxidize-comproportionate over the study time course, these observations suggest a cyanide-stimulated one-electron DQ reduction and durosemiquinone (DQ*-) autoxidation. The latter processes are apparently confined to the cell interior, as the cell membrane impermeant oxidant, ferricyanide, did not inhibit the DQ-stimulated cyanide-insensitive oxygen consumption. Thus, regardless of whether DQ is reduced via a one- or two-electron reduction pathway, the net effect in the extracellular medium is the appearance of DQH2. These endothelial redox functions and their apposition to the vessel lumen are consistent with the pulmonary endothelium being an important site of DQ reduction to DQH2 observed in the lungs. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183197     DOI: 10.1016/j.freeradbiomed.2004.02.078

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

1.  Coenzyme Q(1) as a probe for mitochondrial complex I activity in the intact perfused hyperoxia-exposed wild-type and Nqo1-null mouse lung.

Authors:  Robert D Bongard; Charles R Myers; Brian J Lindemer; Shelley Baumgardt; Frank J Gonzalez; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-20       Impact factor: 5.464

2.  Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells.

Authors:  Robert D Bongard; Gary S Krenz; Adam J Gastonguay; Carol L Williams; Brian J Lindemer; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2011-01-14       Impact factor: 7.376

3.  Quantifying mitochondrial and plasma membrane potentials in intact pulmonary arterial endothelial cells based on extracellular disposition of rhodamine dyes.

Authors:  Zhuohui Gan; Said H Audi; Robert D Bongard; Kathryn M Gauthier; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

4.  Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.

Authors:  Brian J Lindemer; Robert D Bongard; Raymond Hoffmann; Shelley Baumgardt; Frank J Gonzalez; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-02-04       Impact factor: 5.464

5.  Formation of Redox-Active Duroquinone from Vaping of Vitamin E Acetate Contributes to Oxidative Lung Injury.

Authors:  Alexa Canchola; C M Sabbir Ahmed; Kunpeng Chen; Jin Y Chen; Ying-Hsuan Lin
Journal:  Chem Res Toxicol       Date:  2022-01-25       Impact factor: 3.739

6.  Coenzyme Q1 redox metabolism during passage through the rat pulmonary circulation and the effect of hyperoxia.

Authors:  Said H Audi; Marilyn P Merker; Gary S Krenz; Taniya Ahuja; David L Roerig; Robert D Bongard
Journal:  J Appl Physiol (1985)       Date:  2008-08-14

7.  Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.

Authors:  Robert D Bongard; Brian J Lindemer; Gary S Krenz; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2008-09-20       Impact factor: 7.376

8.  Depolarized mitochondrial membrane potential and protection with duroquinone in isolated perfused lungs from rats exposed to hyperoxia.

Authors:  Said H Audi; Swetha Ganesh; Pardis Taheri; Xiao Zhang; Ranjan K Dash; Anne V Clough; Elizabeth R Jacobs
Journal:  J Appl Physiol (1985)       Date:  2021-12-23

9.  Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury.

Authors:  Anita J Reddy; Jason D Christie; Richard Aplenc; Barry Fuchs; Paul N Lanken; Steven R Kleeberger
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.